These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7629609

  • 1. Neuroleptic malignant syndrome: a clinical conundrum.
    Millnamow GA.
    J Okla State Med Assoc; 1995 Jun; 88(6):256-8. PubMed ID: 7629609
    [Abstract] [Full Text] [Related]

  • 2. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death.
    Tural U, Onder E.
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):79-87. PubMed ID: 20416027
    [Abstract] [Full Text] [Related]

  • 3. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD, Ponce FA, Killory BD, Wallace D, Rekate HL.
    J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Lethal catatonia: clinical aspects and therapeutic intervention. A review of the literature].
    Mann SC, Auriacombe M, Macfadden W, Caroff SN, Cabrina Campbell E, Tignol J.
    Encephale; 2001 Sep; 27(3):213-6. PubMed ID: 11488250
    [Abstract] [Full Text] [Related]

  • 12. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD, Pedersen S.
    Ugeskr Laeger; 2000 Mar 06; 162(10):1366-70. PubMed ID: 10745673
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome.
    Granner MA, Wooten GF.
    Semin Neurol; 1991 Sep 06; 11(3):228-35. PubMed ID: 1947485
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic Malignant Syndrome: Diagnosis and Management.
    Ware MR, Feller DB, Hall KL.
    Prim Care Companion CNS Disord; 2018 Jan 04; 20(1):. PubMed ID: 29325237
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [What do we know today about neuroleptic malignant syndrome?].
    Nyquist OG.
    Tidsskr Nor Laegeforen; 1996 Oct 10; 116(24):2879-82. PubMed ID: 8975402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.